News and blogs
413 results found.
Blood Cancer UK's response to the Major Conditions Strategy
The Government has launched a Major Condition Strategy to alleviate pressure on the healthcare system.
CAR-T cell therapy made available on NHS
Yescarta has now been made available for people with certain types of lymphoma on the NHS in England
Blood Cancer UK appoint new chief executive
Blood Cancer UK new chief executive
How are we going to raise awareness of blood cancer?
Find out what Blood Cancer UK are doing to raise the profile of blood cancer.
The origins of childhood leukaemia in twins
Blood Cancer UK's research funding has led to an understanding of the origins of childhood leukaemia in twins.
New ‘universal approach’ therapy for leukaemia shows promise during world-first trial
Blood Cancer UK was proud to fund the lab studies that directly led to this life-changing trial which could broaden the number of people who benefit from this type of therapy in future.
Paxlovid rebound - what we know
Paxlovid rebound is when people recover from covid-19 after taking a course of Paxlovid tablets, but then the infection seems to come back. Find out what this means for people offered treatment with Paxlovid.
Evusheld available in the UK to buy privately
Evusheld is available privately in the UK. Here’s what we know about how to access it.
New campaign launches for the forgotten 500,000 families
Immunocompromised families urge UK government to take action.
Health inequalities: how does stress change our bodies?
Read our blog about how social factors are more likely to impact certain groups.
Dr Sidney Farber's story
Read about Dr Sidney Farber who discovered the role folic acid played in the creation of leukaemia cells and achieved the first clinical remission of leukaemia in children by using a chemical anti agent.
Blood Cancer UK chief executive to join Macmillan
Blood Cancer UK chief executive announces move to Macmillan Cancer Support
MGUS to AML: Ian's Story & Blood Cancer Awareness
For Blood Cancer Awareness Month, Jonathan shares his story in memory of his dad Ian whose MGUS developed into Acute Myeloid Leukaemia. Ian sadly died in May 2022; just 8 weeks after his diagnosis.
Remember Her Majesty the Queen
Remember Her Majesty the Queen
What's the latest on Evusheld?
A look at the latest news on Evusheld
Blood cancer facts
Read about different blood cancer types, whether it's leukaemia, lymphoma, myeloma, MDS, or any other blood cancer.
Five things we learned about blood cancer services from the cancer patient experience survey
Every year, NHS England asks thousands of cancer patients in England about their experiences. We've picked out five key things we think the NHS and Government should be focusing on, which we believe would save a significant number of lives.
Leading charities and clinicians urge Government to secure Evusheld
Over 120 leading clinicians have signed a clinical consensus statement, declaring that the Covid-19 protective antibody treatment Evusheld should be used as soon as possible to protect people most vulnerable to Covid-19.
Making blood cancer and Covid-19 choices that work for you
We know it's still an uncertain time for the blood cancer community, with many people trying to find the right balance between protecting themselves from the virus and looking after their mental well-being.
Survey highlights forgotten pandemic victims
As the country as a whole returns to normal, a quarter of people with blood cancer remain anxious about leaving their home
